生物纳米材料去除抗生素及其抗性基因的机理解析

Mechanistic analysis of antibiotic and antibiotic resistance gene removal using bionanomaterials

  • 摘要: 抗生素在医疗与养殖领域的广泛使用导致其在环境中持续残留,诱导抗生素抗性基因(ARGs)的传播,严重威胁生态安全。文章对生物纳米材料在抗生素降解及ARGs控制领域的研究进展进行了系统综述。根据合成来源,生物纳米颗粒可分为细菌、真菌、藻类及植物合成四类。在抗生素降解方面,生物纳米材料主要通过吸附和催化两种机制发挥作用,其中催化降解进一步分为生物催化(加速电子传递)和化学催化(产生羟基自由基等活性氧物种)。在ARGs控制方面,生物纳米材料一方面通过降解抗生素削减选择压力,另一方面通过物理破坏、化学氧化及生物调控等多重机制直接削弱ARGs传播。生物合成纳米粒子展现出从源头削减抗生素并直接阻断ARGs的双重核心价值,是迈向“从杀菌到控基因”战略的关键一步。

     

    Abstract: Antibiotics are widely used in healthcare and animal farming. This leads to their continuous release into the environment. The residues induce the spread of antibiotic resistance genes (ARGs), posing a serious threat to ecological safety.This article provides a systematic review of bio-nanomaterials for antibiotic degradation and ARGs control. Based on their synthesis source, bio-nanoparticles fall into four categories: bacterial, fungal, algal, and plant-derived.In terms of antibiotic degradation, bio-nanomaterials act mainly through adsorption and catalysis. Catalytic degradation is further divided into biocatalysis (which accelerates electron transfer) and chemical catalysis (which produces reactive oxygen species such as hydroxyl radicals). In terms of ARGs control, bionanomaterials reduce selective pressure through antibiotic degradation on the one hand, while directly suppressing ARGs dissemination through multiple mechanisms including physical disruption, chemical oxidation, and biological regulation on the other. Biosynthesized nanoparticles exhibit the dual core value of reducing antibiotics at the source and directly blocking ARGs transmission, representing a key step toward the strategic shift from “killing bacteria” to “controlling genes.”

     

/

返回文章
返回